Literature DB >> 31673787

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach.

Abass Alavi1, Jorge R Barrio2, Thomas J Werner3, Mohsen Khosravi4, Andrew Newberg4,5, Poul Flemming Høilund-Carlsen6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31673787     DOI： 10.1007/s00259-019-04564-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  40 in total

1.  Demography. Broken limits to life expectancy.

Authors:  Jim Oeppen; James W Vaupel
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

Review 2.  The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors.

Authors:  Paul S Aisen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  About a peculiar disease of the cerebral cortex. By Alois Alzheimer, 1907 (Translated by L. Jarvik and H. Greenson)

Authors: 
Journal:  Alzheimer Dis Assoc Disord       Date:  1987       Impact factor: 2.703

Review 4.  Development of positron emission tomography β-amyloid plaque imaging agents.

Authors:  Chester A Mathis; N Scott Mason; Brian J Lopresti; William E Klunk
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

Review 5.  Normal and abnormal biology of the beta-amyloid precursor protein.

Authors:  D J Selkoe
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

Review 6.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

7.  Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates.

Authors:  Graham B Cole; Gyochang Keum; Jie Liu; Gary W Small; Nagichettiar Satyamurthy; Vladimir Kepe; Jorge R Barrio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-19       Impact factor: 11.205

8.  Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease.

Authors:  W E Klunk; M L Debnath; J W Pettegrew
Journal:  Neurobiol Aging       Date:  1994 Nov-Dec       Impact factor: 4.673

9.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.

Authors:  Z Nagy; M M Esiri; K A Jobst; J H Morris; E M King; B McDonald; S Litchfield; A Smith; L Barnetson; A D Smith
Journal:  Dementia       Date:  1995 Jan-Feb

10.  The amyloid hypothesis on trial.

Authors:  Simon Makin
Journal:  Nature       Date:  2018-07       Impact factor: 49.962
View more
  1 in total

1.  Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?

Authors:  Poul F Høilund-Carlsen; Thomas J Werner; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Clin Nucl Med       Date:  2022-04-22       Impact factor: 10.782
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.